30 July 2013 LipImage™ 815: novel dye-loaded lipid nanoparticles for long-term and sensitive in vivo near-infrared fluorescence imaging
Author Affiliations +
Abstract
A new contrast agent, LipImage™ 815, has been designed and compared to previously described indocyanine green (ICG)-loaded lipid nanoparticles (ICG-lipidots®). Both contrast agents display similar size (50-nm diameter), zeta potential, high IC50 in cellular studies, near-infrared absorption and emission wavelengths in the “imaging window,” long-term shelf colloidal and optical stabilities with high brightness (<10 6   L mol −1  cm −1 ) in ready-to-use storage conditions in aqueous buffer (4°C in dark), therefore being promising fluorescence contrast agents for in vivo imaging. However, while ICG-lipidots® display a relatively short plasma lifetime, LipImage™ 815 circulates in blood for longer times, allowing the efficient uptake of fluorescence signal in human prostate cancer cells implanted in mice. Prolonged tumor labeling is observed for more than 21 days.
© 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)
Aurelie Jacquart, Michelle Keramidas, Julian Vollaire, Raphaël Boisgard, Géraldine Pottier, Emilie Rustique, Frédérique Mittler, Fabrice Navarro, Jerome Boutet, Jean-Luc Coll, Isabelle Texier, "LipImage™ 815: novel dye-loaded lipid nanoparticles for long-term and sensitive in vivo near-infrared fluorescence imaging," Journal of Biomedical Optics 18(10), 101311 (30 July 2013). https://doi.org/10.1117/1.JBO.18.10.101311 . Submission:
JOURNAL ARTICLE
9 PAGES


SHARE
Back to Top